# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-036104
Filing Date
2024-08-08
Accepted
2024-08-08 16:03:19
Documents
86
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | arwr-20240630.htm iXBRL | 10-Q | 1243472
2 | EX-31.1 | arwr-2024630xex311.htm | EX-31.1 | 624
3 | EX-31.2 | arwr-2024630xex312.htm | EX-31.2 | 624
4 | EX-32.1 | arwr-2024630xex321.htm | EX-32.1 | 624
5 | EX-32.2 | arwr-2024630xex322.htm | EX-32.2 | 624
11 | GRAPHIC | arwr-2024630xex311001.jpg | GRAPHIC | 201061
12 | GRAPHIC | arwr-2024630xex312001.jpg | GRAPHIC | 198002
13 | GRAPHIC | arwr-2024630xex321001.jpg | GRAPHIC | 85362
14 | GRAPHIC | arwr-2024630xex322001.jpg | GRAPHIC | 84194
| Complete submission text file | 0001628280-24-036104.txt |  | 8093006

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | arwr-20240630.xsd | EX-101.SCH | 55929
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | arwr-20240630_cal.xml | EX-101.CAL | 71242
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | arwr-20240630_def.xml | EX-101.DEF | 254829
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | arwr-20240630_lab.xml | EX-101.LAB | 664333
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | arwr-20240630_pre.xml | EX-101.PRE | 487020
89 | EXTRACTED XBRL INSTANCE DOCUMENT | arwr-20240630_htm.xml | XML | 1070162

Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 241188083
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)